Ferric iron uptake into cardiomyocytes of β-thalassemic mice is not through calcium channels

References

• Andrews, N. C. (1999). Disorders of iron metabolism. N Engl J Med 341:1986–1995.
   PubMed Web of Science ®Google Scholar
• Breuer, W., Hershko, C., Cabantchik, Z. I. (2000). The importance of non-transferrin bound iron in disorders of iron metabolism. Transfus Sci 23:185–192.
   PubMedGoogle Scholar
• Brittenham, G. M., Griffith, P. M., Nienhuis, A. W., McLaren, C. E., Young, N. S., Tucker, E. E., et al. (1994). Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 331:567–573.
   PubMed Web of Science ®Google Scholar
• Dunn, L. L., Rahmanto, Y. S., Richardson, D. R. (2007). Iron uptake and metabolism in the new millennium. Trends Cell Biol 17:93–100.
   PubMed Web of Science ®Google Scholar
• Finney, L. A., O’Halloran, T. V. (2003). Transition metal speciation in the cell: insights from the chemistry of metal ion receptors. Science 300:931–936.
   PubMed Web of Science ®Google Scholar
• Fukuda, K. (2003). Use of adult marrow mesenchymal stem cells for regeneration of cardiomyocytes. Bone Marrow Transplant 32(Suppl 1):S25–S27.
   Google Scholar
• Glickstein, H., El, R. B., Link, G., Breuer, W., Konijn, A. M., Hershko, C., et al. (2006). Action of chelators in iron-loaded cardiac cells: accessibility to intracellular labile iron and functional consequences. Blood 108:3195–3203.
   PubMed Web of Science ®Google Scholar
• Hentze, M. W., Muckenthaler, M. U., Andrews, N. C. (2004). Balancing acts: molecular control of mammalian iron metabolism. Cell 117:285–297.
   PubMed Web of Science ®Google Scholar
• Huang, B., Qin, D., Deng, L., Boutjdir, M. N. E.-S. (2000). Reexpression of T-type Ca2+ channel gene and current in post-infarction remodeled rat left ventricle. Cardiovasc Res 46:442–449.
   PubMed Web of Science ®Google Scholar
• Jamsai, D., Zaibak, F., Khongnium, W., Vadolas, J., Voullaire, L., Fowler, K. J., et al. (2005). A humanized mouse model for a common beta0-thalassemia mutation. Genomics 85:453–461.
   PubMed Web of Science ®Google Scholar
• Jamsai, D., Zaibak, F., Vadolas, J., Voullaire, L., Fowler, K. J., Gazeas, S., et al. (2006). A humanized BAC transgenic/knockout mouse model for HbE/beta-thalassemia. Genomics 88:309–315.
   PubMed Web of Science ®Google Scholar
• Ke, Y., Chen, Y. Y., Chang, Y. Z., Duan, X. L., Ho, K. P., Jiang, D. H., et al. (2003). Post-transcriptional expression of DMT1 in the heart of rat. J Cell Physiol 196:124–130.
   PubMedGoogle Scholar
• Kumfu, S., Chattipakorn, S., Chinda, K., Fucharoen, S., Chattipakorn, N. (2012). T-type calcium channel blockade improves survival and cardiovascular function in thalassemic mice. Eur J Haematol 88:535–548.
   PubMed Web of Science ®Google Scholar
• Kumfu, S., Chattipakorn, S., Srichairatanakool, S., Settakorn, J., Fucharoen, S., Chattipakorn, N. (2011). T-type calcium channel as a portal of iron uptake into cardiomyocytes of beta-thalassemic mice. Eur J Haematol 86:156–166.
   PubMed Web of Science ®Google Scholar
• Li, Z., Gu, T. X., Zhang, Y. H. (2008). Hepatocyte growth factor combined with insulin like growth factor-1 improves expression of GATA-4 in mesenchymal stem cells cocultured with cardiomyocytes. Chin Med J (Engl) 121:336–340.
   PubMed Web of Science ®Google Scholar
• Liu, Y., Parkes, J. G., Templeton, D. M. (2003). Differential accumulation of non-transferrin-bound iron by cardiac myocytes and fibroblasts. J Mol Cell Cardiol 35:505–514.
   PubMed Web of Science ®Google Scholar
• Martinez, M. L., Heredia, M. P., Delgado, C. (1999). Expression of T-type Ca(2+) channels in ventricular cells from hypertrophied rat hearts. J Mol Cell Cardiol 31:1617–1625.
   PubMed Web of Science ®Google Scholar
• McKie, A. T., Barrow, D., Latunde-Dada, G. O., Rolfs, A., Sager, G., Mudaly, E., et al. (2001). An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 291:1755–1759.
   PubMed Web of Science ®Google Scholar
• Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63.
   PubMed Web of Science ®Google Scholar
• Olivieri, N. F. (1999). The beta-thalassemias. N Engl J Med 341:99–109.
   PubMed Web of Science ®Google Scholar
• Olivieri, N. F., Nathan, D. G., MacMillan, J. H., Wayne, A. S., Liu, P. P., McGee, A., et al. (1994). Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med 331:574–578.
   PubMed Web of Science ®Google Scholar
• Oudit, G. Y., Sun, H., Trivieri, M. G., Koch, S. E., Dawood, F., Ackerley, C., et al. (2003). L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med 9:1187–1194.
   PubMed Web of Science ®Google Scholar
• Parkes, J. G., Liu, Y., Sirna, J. B., Templeton, D. M. (2000). Changes in gene expression with iron loading and chelation in cardiac myocytes and non-myocytic fibroblasts. J Mol Cell Cardiol 32:233–246.
   PubMed Web of Science ®Google Scholar
• Parkes, J. G., Olivieri, N. F., Templeton, D. M. (1997). Characterization of Fe2+ and Fe3+ transport by iron-loaded cardiac myocytes. Toxicology 117:141–151.
   PubMed Web of Science ®Google Scholar
• Rodriguez, A., Hilvo, M., Kytomaki, L., Fleming, R. E., Britton, R. S., Bacon, B. R., et al. (2007). Effects of iron loading on muscle: genome-wide mRNA expression profiling in the mouse. BMC Genomics 8:379.
   Web of Science ®Google Scholar
• Shvartsman, M., Kikkeri, R., Shanzer, A., Cabantchik, Z. I. (2007). Non-transferrin-bound iron reaches mitochondria by a chelator-inaccessible mechanism: biological and clinical implications. Am J Physiol Cell Physiol 293:C1383–C1394.
   PubMed Web of Science ®Google Scholar
• Templeton, D. M., Liu, Y. (2003). Genetic regulation of cell function in response to iron overload or chelation. Biochim Biophys Acta 1619:113–124.
   PubMed Web of Science ®Google Scholar
• Tsushima, R. G., Wickenden, A. D., Bouchard, R. A., Oudit, G. Y., Liu, P. P., et al. (1999). Modulation of iron uptake in heart by L-type Ca2+ channel modifiers: possible implications in iron overload. Circ Res 84:1302–1309.
   PubMed Web of Science ®Google Scholar
• Wood, J. C., Enriquez, C., Ghugre, N., Otto-Duessel, M., Aguilar, M., Nelson, M. D., et al. (2005). Physiology and pathophysiology of iron cardiomyopathy in thalassemia. Ann N Y Acad Sci 1054:386–395.
   PubMed Web of Science ®Google Scholar